Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489316 · ClinicalTrials.gov registry record · NA
Narrative Medicine and Pediatric Oncology
A NA study of Pediatric Residents Rotating in Pediatric Oncology, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
- 1
- Study location
NCT04489316 is a NA study of Pediatric Residents Rotating in Pediatric Oncology that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 66 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04489316, a NA study of Pediatric Residents Rotating in Pediatric Oncology, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators' objective is to implement an innovative curriculum in narrative medicine for pediatric residents rotating at Memorial Sloan Kettering Cancer Center (MSKCC), and to evaluate whether this curriculum is protective against burnout and diminished quality of life during that rotation as measured on The Maslach Burnout Inventory-Human Services Survey (MBI-HSS) and The Professional Quality of Life Scale: Compassion Satisfaction, Burnout, and Fatigue Scale Version V (ProQOL R-V).
Conditions Studied
Interventions
- OTHER Narrative medicine curriculum
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2020-07-01 |
| Est. Completion | 2021-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04489316
The ClinicalTrials.gov registry entry for NCT04489316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric Residents Rotating in Pediatric Oncology appearing as the primary indexed condition, and to 1 intervention - of which Narrative medicine curriculum is the first listed.
NCT04489316 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04489316 about?
NCT04489316 is a clinical study titled "Narrative Medicine and Pediatric Oncology". The investigators' objective is to implement an innovative curriculum in narrative medicine for pediatric residents rotating at Memorial Sloan Kettering Cancer Center (MSKCC), and to evaluate whether this curriculum is protective against burnout and diminished quality of life during that rotation as...
What is the current status of trial NCT04489316?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2020-07-01. Estimated completion is 2021-07-01.
What conditions does trial NCT04489316 study?
This clinical trial studies the following conditions: Pediatric Residents Rotating in Pediatric Oncology.
What interventions are being tested in trial NCT04489316?
The interventions under investigation include: Narrative medicine curriculum (OTHER).
Who is sponsoring clinical trial NCT04489316?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04489316 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.